Lucy Shaw

Contributor

tags: AI in Drug Discovery AI in Healthcare Big Data and Data Management in Biomedical Research Biomarkers Development Biomedical Research Biotech Research Cheminformatics/Bioinformatics Clinical Trials Drug Discovery and Development Healthcare Technologies Pharmaceutical Manufacturing RNA-focused Drug Discovery Research Equipment and Tools Artificial Intelligence Assay Technology Big Data Biologics Biopharma news Biotech Startup COVID-19 CRISPR CROs Digital Technologies Healthcare Machine Learning Pharmaceutical industry trends Sequencing Startups Upcoming Events coronavirus

Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

Posts by this author

Scitara joins BioPhorum global collaboration to drive scientific advancements in biopharmaceutical sector

Scitara, proven innovator in laboratory digital transformation, announces it has become a member of BioPhorum, a global community that enables collaboration throughout the biopharmaceutical industry with the goal of accelerating scientific advancements.

Scitara Corp. raises $15m in Series B Financing to disrupt the laboratory data integration market

MOBILion Systems Rolls Out Red Carpet for MOBIE® at Hometown American Society for Mass Spectrometry Event

Research Reveals Trivalent PROTACs More Potent in Targeted Protein Degradation

University of Dundee and Promega researchers show three heads are better than two in novel drug discovery concept

Global Pharmaceutical Company proves validity of AI in life sciences through Pangaea Data’s novel Natural Language Generation driven product

Leading global pharmaceutical company presented Pangaea Data’s Novel AI to Automatically Generate Textual Clinical Narratives for Regulatory Reports

Applications of Bioluminescent Research Tools Showcased at Global Seminar Series

Life science and drug discovery researchers from around the world will explore possibilities of luciferase technologies at Promega Discover Glo 2021 online event September 13-16.

Sepha hits one micron target with new HD leak tester

Sepha has achieved micro leak detection down to one micron (1μm) with the development of a new high performance leak tester for CCIT (Container Closure Integrity Testing) applications. Utilising the vacuum decay test method, the new Multi-Q HD unit takes integrity testing to the next level, enabling ultra-sensitive, non-destructive detection of defects in pharmaceutical containers. This enhanced testing functionality responds to demand from parenteral formats, which are experiencing unprecedented growth on the back of international Covid-19 vaccination programmes.

Cmed Technology adds more capabilities to its encapsia platform and reports increased demand for use in decentralized trials

Innovative technology for clinical trials is now, more than ever, necessary to deliver decentralized trials (DCT) and enable design of hybrid protocols that support trial continuity and patient-centricity

CMED GROUP joins AIXIAL GROUP, the CRO of ALTEN GROUP

AIXIAL GROUP becomes a leading mid-size, worldwide CRO with strong US and European presence and more than
1,000 employees.